Roszet Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with Roszet
L
- lamivudine / zidovudine
- Larin 1.5 / 30 (ethinyl estradiol / norethindrone)
- Larin 1 / 20 (ethinyl estradiol / norethindrone)
- Larin 24 Fe (ethinyl estradiol / norethindrone)
- Larin Fe 1.5 / 30 (ethinyl estradiol / norethindrone)
- Larin Fe 1 / 20 (ethinyl estradiol / norethindrone)
- Larissia (ethinyl estradiol / levonorgestrel)
- Larodopa (levodopa)
- lasmiditan
- Layolis Fe (ethinyl estradiol / norethindrone)
- ledipasvir / sofosbuvir
- Leena (ethinyl estradiol / norethindrone)
- leflunomide
- lenalidomide
- leniolisib
- Leribane (ethinyl estradiol / norethindrone)
- Lescol (fluvastatin)
- Lescol XL (fluvastatin)
- Lessina (ethinyl estradiol / levonorgestrel)
- letermovir
- letrozole / ribociclib
- leuprolide / norethindrone
- Levlen (ethinyl estradiol / levonorgestrel)
- Levlite (ethinyl estradiol / levonorgestrel)
- levodopa
- levoketoconazole
- Levonest (ethinyl estradiol / levonorgestrel)
- levonorgestrel
- Levora (ethinyl estradiol / levonorgestrel)
- lidocaine / sodium bicarbonate
- Likmez (metronidazole)
- Liletta (levonorgestrel)
- Lillow (ethinyl estradiol / levonorgestrel)
- linezolid
- Lipidil EZ (fenofibrate)
- Lipidil Micro (fenofibrate)
- Lipidil Supra (fenofibrate)
- Lipitor (atorvastatin)
- Lipofen (fenofibrate)
- Liptruzet (atorvastatin / ezetimibe)
- Liqui-Dual Citra (citric acid/sodium citrate)
- Livalo (pitavastatin)
- Livmarli (maralixibat)
- Livtencity (maribavir)
- Lo Loestrin Fe (ethinyl estradiol / norethindrone)
- Lo Minastrin Fe (ethinyl estradiol / norethindrone)
- Lo Simpesse (ethinyl estradiol / levonorgestrel)
- Lo-Malmorede (ethinyl estradiol / ethynodiol)
- Lo-Zumandimine (drospirenone / ethinyl estradiol)
- Lo / Ovral (ethinyl estradiol / norgestrel)
- Lo / Ovral-28 (ethinyl estradiol / norgestrel)
- Locholest (cholestyramine)
- Locholest Light (cholestyramine)
- Lodoco (colchicine)
- Loestrin 21 1.5 / 30 (ethinyl estradiol / norethindrone)
- Loestrin 21 1 / 20 (ethinyl estradiol / norethindrone)
- Loestrin 24 Fe (ethinyl estradiol / norethindrone)
- Loestrin Fe 1.5 / 30 (ethinyl estradiol / norethindrone)
- Loestrin Fe 1 / 20 (ethinyl estradiol / norethindrone)
- Lofibra (fenofibrate)
- LoJaimiess (ethinyl estradiol / levonorgestrel)
- Lomedia 24 Fe (ethinyl estradiol / norethindrone)
- lomitapide
- Lopid (gemfibrozil)
- lopinavir / ritonavir
- Lopreeza (estradiol / norethindrone)
- Lorbrena (lorlatinib)
- lorlatinib
- Loryna (drospirenone / ethinyl estradiol)
- LoSeasonique (ethinyl estradiol / levonorgestrel)
- Losospan (magaldrate)
- Losospan Plus (magaldrate / simethicone)
- lovastatin
- lovastatin / niacin
- Low-Ogestrel-28 (ethinyl estradiol / norgestrel)
- Lowsium (magaldrate)
- Lowsium Plus (magaldrate / simethicone)
- Lumakras (sotorasib)
- Lunelle (estradiol / medroxyprogesterone)
- Lunsumio (mosunetuzumab)
- Lupaneta Pack (leuprolide / norethindrone)
- Lupkynis (voclosporin)
- Lutera (ethinyl estradiol / levonorgestrel)
- Lybrel (ethinyl estradiol / levonorgestrel)
- Lyleq (norethindrone)
- Lynparza (olaparib)
- Lypqozet (atorvastatin / ezetimibe)
- Lytgobi (futibatinib)
- Lyza (norethindrone)
More about Roszet (ezetimibe / rosuvastatin)
- Roszet consumer information
- Check interactions
- Compare alternatives
- Imprints, shape & color data
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: antihyperlipidemic combinations
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.